Global Health Governance in Conflict Zones: Strengthening Infection Prevention and Control to Mitigate Antimicrobial Resistance
Original framing: “[Correspondence] Microbiological governance and the Lancet Commission on Ukraine – Authors' reply” — The Lancet
Scientific evidence from epidemiological studies and laboratory research confirms the urgent need for action on antimicrobial resistance. However, the narrative fails to address the limitations and biases of these studies, which often prioritize Western perspectives and neglect the experiences of marginalized communities.
The Lancet Commission's work on Ukraine highlights the urgent need for action on antimicrobial resistance in conflict zones.
Strengthening infection prevention and control measures is essential for improving patient safety and reducing the burden of hospital-acquired infections. However, this requires a coordinated global effort to address the root causes of antimicrobial resistance, including conflict, poverty, and inequality. By promoting community-based health initiatives, addressing the structural causes of conflict, and strengthening infection prevention and control measures, we can mitigate the spread of antimicrobial-resistant infections and promote global health security. The experience of healthcare workers and patients in conflict zones can inform strategies for improving infection prevention and control, and the perspectives of marginalized communities can provide valuable insights into the prevention and treatment of antimicrobial-resistant infections. Ultimately, a nuanced understanding of the complex interactions between healthcare systems, conflict, and antimicrobial resistance is essential for developing effective solutions to this global health crisis.